Bio-Techne (TECH) is trading down at $72.43 (-0.03%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Goldman raises Asia-Pacific equity target on tech earnings outlook
Goldman raises Asia-Pacific equity target on tech earnings outlook
Nextech3D.ai first quarter revenue doubles as event tech scales - ICYMI
Nextech3D.ai first quarter revenue doubles as event tech scales - ICYMI
Tech Stock Rally Rolls On as Bond Yields Slide Ahead of Jobs Report
Tech Stock Rally Rolls On as Bond Yields Slide Ahead of Jobs Report